산소치료 세계 시장 규모는 2024년 201억 5,000만 달러에 달했습니다. 2033년까지 343억 7,000만 달러에 달하고, 2025-2033년 6.05%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 현재 북미가 시장을 독점하고 있으며, 2024년 시장 점유율은 37.9%를 초과할 것으로 예측됩니다. 전 세계 산소치료 시장은 호흡기 질환 유병률 증가와 재택의료 선호도 증가로 인해 빠르게 성장하고 있습니다. 시장을 형성하는 주목할 만한 동향으로는 휴대용 및 착용형 산소 공급 시스템의 발전, 스마트 기술 도입, 환자 개개인의 요구에 맞는 치료의 중요성 등을 들 수 있습니다.
산소치료 시장은 주로 만성폐쇄성폐질환(COPD), 천식 등 장기적인 산소치료가 필요한 질환의 유병률 증가가 주도하고 있습니다. 예를 들어, 에머슨은 호흡 치료 레이아웃을 위한 완벽한 패키지이자 시장 출시 시간을 단축하기 위해 ASCO(TM) Series 588 고정식 산소 농축기 매니폴드를 개발했습니다. 또한, 강화된 휴대용 산소 농축기는 모바일 지원을 제공하므로 재택치료의 필요에 따라 쉽게 설치할 수 있어 시장 성장을 가속하고 있습니다. 또한, 고령화 사회에서는 호흡기 질환의 발병 빈도가 높아지면서 산소요법 시장 점유율이 크게 확대되고 있습니다. 이 외에도 산소치료과 관련된 이점에 대한 이해가 깊어지면서 전 세계적으로 산소 사용이 촉진되어 시장에 활력을 불어넣고 있습니다. 이와는 별도로, 산소 농축기의 지속적인 기술 혁신은 치료 효과를 높이고 시장 성장의 촉매제가 되고 있습니다.
산소치료 시장에서 미국은 88.70%의 점유율을 차지하고 있습니다. 이 지역에서는 호흡기 질환, 특히 COPD의 발병률이 증가함에 따라 수요가 확대되고 있습니다. 또한, 의료비 및 보험료 증가가 산소요법 수요를 견인하며 시장 성장을 뒷받침하고 있습니다. 동시에 재택치료 기술의 지속적인 발전으로 환자가 집에서 산소치료을 받을 수 있게 되어 시장 수요를 촉진하고 있습니다. 또한, 호흡기 건강이 얼마나 소중한 것인지에 대한 일반인들의 인식이 높아지면서 조기 치료가 촉진되고 시장 점유율이 확대되고 있습니다. 이와는 별도로 대기오염이 호흡기 질환의 부담을 증가시키기 때문에 만성질환 관리에 대한 정부의 이니셔티브는 산소 처방을 증가시켜 시장을 발전시키고 있습니다.
재택 헬스케어 동향
많은 환자들, 특히 노인이나 만성질환 환자들은 병원이나 요양시설이 아닌 자택에서의 치료를 선호합니다. 재택치료는 장비가 휴대가 가능하고 관리가 용이하며, 비교적 저렴한 경우가 많으며, 환자는 이동과 자유를 유지할 수 있습니다. IMARC Group에 따르면, 세계 재택치료 시장은 2023년 3,922억 달러에 달할 것으로 예측됩니다. COPD나 폐섬유증과 같은 만성 호흡기 질환의 대부분은 장기적인 산소치료을 필요로 합니다. 또한, 재택치료는 모든 질병 관리 도구로 널리 사용되고 있으며, 치료 요법 준수에 부합하여 산소치료 시장의 성장을 가속하고 있습니다.
호흡기 질환 증가
2023년 세계보건기구(WHO) 웹사이트에 게재된 기사에 따르면, 세계 3위 사망원인은 COPD로 2019년에는 323만 명이 사망했습니다. COPD, 천식, 간질성 폐질환, 폐렴 등 매우 흔한 질환의 증상 치료에 있어 산소요법은 매우 중요합니다. 호흡기 질환은 해롭고, 장기적인 치료만이 환자를 구할 수 있기 때문입니다. 또한, 산소치료은 만성 호흡기 질환에 대한 혈액 내 충분한 산소 처방에 있어 매우 중요하며, 시장 성장을 가속하고 있습니다.
고령화
노인들은 COPD, 폐기종, 폐렴 등 호흡기 질환을 자주 앓고 있으며, 산소요법을 사용하는 것이 유일한 치료법으로 알려져 있습니다. 또한 노인의 호흡기 질환은 고혈압, 심장병, 당뇨병 등 다른 질환을 동반할 수 있으며, 이러한 질환은 호흡기 질환을 악화시키므로 산소요법의 사용이 필수적입니다. 노인의 특징은 큰 호흡기 질환으로 이어지는 몇 가지 감염을 끌어들이는 면역 체계입니다. 또한, 노인은 면역력이 약해져 있기 때문에 심각한 호흡기 질환을 앓고 있습니다. 국제통화기금(IMF) 전자도서관 웹사이트에 게재된 기사에 따르면, 2050년까지 전 세계 80세 이상 노인의 비율이 4배로 증가하여 거의 5%에 육박할 것으로 예측됩니다.
시장 판도를 바꾸는 새로운 전개
시장은 여러 가지 동시다발적인 발전의 영향을 받으면서도 꾸준히 성장하고 있습니다. 주요 요인은 만성 호흡기 질환, 특히 COPD, 수면무호흡증, 폐섬유증의 유병률 증가입니다. 미국 업계 조사에 따르면, 30세에서 70세 사이의 성인 26%가 최소 경미한 폐쇄성 수면무호흡증을 앓고 있으며, 10%는 중등도에서 중증의 수면무호흡증을 앓고 있는 것으로 밝혀졌습니다. 이 때문에 장기적인 산소 지원에 대한 수요가 지속적으로 증가하고 있습니다. 이와 함께 제조업체들은 휴대용 및 착용형 산소 공급 시스템에 주목하고 있습니다. 소형 산소 농축기 및 경량 웨어러블 장치를 통해 사용자는 이동성을 유지하여 집이나 여행지에서 더 편리하게 사용할 수 있습니다. 이와 더불어, 임상의와 장비 제조업체가 개인의 필요에 따라 산소 유량 및 공급 모드를 조정하려고 시도함에 따라 개인 맞춤형 산소치료이 주목받고 있습니다. 동시에, 특히 휴대용 및 스마트형 산소 공급 장치에 대한 규제 당국의 승인이 증가하고 있는 것은 안전성이 향상되고 시장의 신뢰가 높아진 것을 반영합니다. 또한, 장비 제조업체, 병원, 재택치료 서비스 제공업체 간의 전략적 제휴는 제품의 기술 혁신을 더욱 촉진하고, 임상 및 비임상 현장 모두에서 더 광범위한 채택을 촉진하고 있습니다.
The global oxygen therapy market size was valued at USD 20.15 Billion in 2024. The market is projected to reach USD 34.37 Billion by 2033, exhibiting a CAGR of 6.05% from 2025-2033. North America currently dominates the market, holding a market share of over 37.9% in 2024. The oxygen therapy market worldwide is expanding rapidly due to a higher incidence of respiratory conditions and a growing preference for home-based medical care. Notable trends shaping the market include advances in portable and wearable oxygen delivery systems, the incorporation of smart technologies, and greater emphasis on tailoring therapy to individual patient needs.
The oxygen therapy market is primarily driven by the increasing incidence of diseases such as chronic obstructive pulmonary disease (COPD) and asthma, which require long-term oxygen therapy. For instance, Emerson developed the ASCO(TM) Series 588 Stationary Oxygen Concentrator Manifold as a complete package for respiratory therapy layouts and to help expedite time to market. In addition, the enhanced portable oxygen devices give mobile support, which allows easy installation for in-home healthcare needs, aiding the market growth. Moreover, the percentage of the aging population group triggers respiratory illnesses more frequently, which is significantly expanding the oxygen therapy market share. Besides this, the increased understanding of the benefits associated with oxygen therapy is boosting the use of oxygen across the globe, providing an impetus to the market. Apart from this, the continuous innovation in oxygen concentrators enhances the impact of treatment, thereby catalyzing the market growth.
The United States holds a share of 88.70% in the oxygen therapy market. The demand in the region is expanding, due to the increasing incidence of diseases of the respiratory system, especially COPD. Moreover, the increase in health care costs and insurance is driving the demand for oxygen therapies, supporting the market growth. Concurrently, continuous developments in home healthcare technology make it possible for patients to receive oxygen therapy at home, which is fueling the market demand. Also, higher public awareness of how respiratory health is valuable promotes early treatment, thus strengthening the market share. Apart from this, the government initiatives for chronic disease management increase oxygen prescription, as air pollution increases the burden of respiratory diseases, thereby propelling the market forward.
Home healthcare trends
Most patients especially the elderly and those with chronic diseases prefer to be treated at home instead of in hospitals or nursing homes. At-home care is often relatively cheaper as the devices are portable, and easy to manage, allowing the patient to maintain their mobility and freedom. The IMARC Group reports that the global home healthcare market reached USD 392.2 Billion in 2023. Most chronic respiratory conditions such as COPD and pulmonary fibrosis require oxygen therapy for the long term. Additionally, home healthcare is widely used as a tool for the management of all illnesses, aligning with the compliance of treatment regimens and impelling the oxygen therapy market growth.
Increasing prevalence of respiratory diseases
According to an article published on the website of the World Health Organization (WHO) in 2023, the third leading cause of death worldwide is COPD, causing 3.23 million deaths in 2019. Oxygen therapy is extremely necessary during the treatment of symptoms of quite common diseases such as COPD, asthma, interstitial lung disease, or pneumonia. This is because respiratory ailments are injurious, and only extended treatment can help those patients, who have such conditions. Furthermore, oxygen therapy is of great importance in the prescription of sufficient oxygen in the blood for chronic respiratory illnesses, thus impelling market growth.
Aging population
The elderly patients suffer frequent respiratory conditions including COPD, emphysema as well as pneumonia, and the only known cure is the use of oxygen therapy. Respiratory diseases in old people may also be accompanied by other diseases such as hypertension, heart disease, and diabetes, which worsen respiratory diseases and therefore make oxygen therapy mandatory. Features characteristic of elders are the immune system that draws several infections leading to major respiratory illnesses. The elders also suffer from severe respiratory illnesses due to low immune system strength. An article published on the website of the International Monetary Fund (IMF) eLibrary shows that by 2050 the global share of people aged 80 and older is expected to quadruple to almost 5%.
Emerging Developments Reshaping the Market Landscape
The market is witnessing steady growth, influenced by several concurrent developments. A primary factor is the rising incidence of chronic respiratory diseases, particularly COPD, sleep apnea, and pulmonary fibrosis. Highlighting the widespread nature of sleep apnea, an industry study in the United States revealed that 26% of adults aged 30 to 70 exhibited at least mild obstructive sleep apnea, while 10% were found to have moderate to severe forms of the condition. This continues to drive demand for long-term oxygen support. Alongside this, manufacturers are focusing on portable and wearable oxygen delivery systems. Compact oxygen concentrators and lightweight wearable units allow users to maintain mobility, making home and travel use more convenient. In addition to this, personalized oxygen therapy is gaining attention as clinicians and device manufacturers seek to tailor oxygen flow rates and delivery modes to individual needs. Simultaneously, an uptick in regulatory approvals, particularly for portable and smart oxygen delivery devices, reflects both safety advancements and growing market confidence. Also, strategic collaborations between device manufacturers, hospitals, and home healthcare providers have further supported product innovation and broader adoption across both clinical and non-clinical settings.
Oxygen source equipment stands as the largest component in 2024, holding around 57.6% of the market. It is essential for oxygen treatment because it supplies patients with the oxygen they require. Without these devices, it would be hard to provide oxygen to patients in need, making them market-essential. These devices are used in various contexts, including hospitals, clinics, and home healthcare facilities. Their adaptability and requirement in many healthcare settings are driving their strong adoption. Moreover, continuous advancements and improvements in oxygen source equipment, such as portable and lightweight designs, enhanced efficiency, and user-friendly features, are transforming the oxygen therapy market overview.
Chronic obstructive pulmonary disease (COPD) leads the market with around 32.9% of the market share in 2024. The high incidence of COPD directly corresponds to a large patient population requiring oxygen therapy, making it the most common application area. COPD is a progressive and chronic ailment that usually worsens with time, and strongly demands long-term care procedures and treatment. Patients with COPD may require continuous or intermittent oxygen therapy to control symptoms and maintain their quality of life. Oxygen treatment alleviates respiratory difficulties and severe shortness of breath, making it an essential part of COPD management, thereby positively influencing the oxygen therapy market insights.
Home healthcare holds the largest market with around 32% of the market share in 2024. Many patients prefer to be treated at home rather than in hospitals or clinics for treatment. Home healthcare allows patients to continue their routines and stay in familiar environments, which benefits their overall well-being and satisfaction with the services. Additionally, home healthcare is more cost-effective than inpatient treatment in general. It eliminates long hospitalizations, reduces health costs, and relieves the burden on hospitals. This cost-saving is attractive to patients and healthcare providers. In portable oxygen concentrators and other home-use oxygen delivery systems, medical technology has made oxygen therapy more manageable for patients at home. Many of these gadgets have become easier to use, faster, and lightweight enhancing their application in the homes.
In 2024, North America accounted for the largest market share of 37.9%. There is a high incidence of respiratory diseases in the region including COPD, asthma, and sleep apnea due to several factors including aging, smoking, and pollution. The availability of sophisticated technologies, easy access to these technologies, and robust reimbursement strategies all contribute to the growth of the market. In addition, the growth of home care and portable and easy-to-use oxygen therapy devices enhance the ability of patients to manage their diseases from their homes. Furthermore, important players in this area are interested in increasing the storage capacities of oxygen. For instance, in 2024 Chart Industries announced the grand opening of its jumbo cryogenic tank manufacturing facility in Theodore, Alabama.
United States Oxygen Therapy Market Analysis
The adoption of oxygen therapy is witnessing a notable rise, fueled by the increasing investments in healthcare systems. For instance, in 2024, US healthcare companies securing venture capital deals over USD 15 Million saw a surge in investments, benefiting oxygen therapy advancements. This growth enhances access to innovative treatments, improving patient care and outcomes. As healthcare expenditures continue to grow, there is a greater emphasis on improving patient care, particularly for those with respiratory disorders. Enhanced healthcare infrastructures and access to advanced treatments have led to a higher demand for therapies such as oxygen therapy. The growing awareness of respiratory diseases and their impact on quality of life further drives the demand for these treatments. As the need for specialized care expands, healthcare facilities are better equipped to administer oxygen therapy, making it more accessible to patients in need. The increase in research funding and technological advancements in oxygen delivery systems are also contributing to the rise in therapy adoption, offering more efficient and comfortable solutions for individuals with respiratory challenges.
Europe Oxygen Therapy Market Analysis
Chronic diseases have been steadily rising, leading to an increasing need for oxygen therapy as a crucial part of patient management. The rising incidence of chronic conditions, such as COPD and heart diseases, requires long-term treatment, often involving oxygen support. The growing number of aging individuals, many of whom suffer from chronic ailments, has also played a significant role in the increased demand for oxygen therapy. For instance, in 2022, 2.9% of the EU population was aged 85 or older, with projections indicating this share will surpass 10% by 2050. This demographic shift highlights the increasing demand for oxygen therapy. Hospitals and medical care facilities are increasingly focusing on advanced therapies to support these patients. Moreover, the importance of oxygen therapy in improving their quality of life has been well recognized. New treatment protocols and greater access to home-based oxygen support devices contribute to the widespread adoption, further supporting oxygen therapy market growth. As healthcare institutions continue to prioritize the treatment of chronic conditions, the adoption of oxygen therapy has become a vital element in improving long-term patient outcomes, particularly for individuals with ongoing respiratory needs.
Asia Pacific Oxygen Therapy Market Analysis
Asthma cases are on the rise across the region, leading to a surge in the adoption of oxygen therapy. For instance, asthma affects over 35 million people in India, contributing significantly to the growing number of asthma patients. Oxygen therapy offers a promising solution to alleviate symptoms and improve the quality of life for asthma patients. As asthma becomes more prevalent, patients need proper and constant therapy because of the rising frequency of the disease. This has led to an increased need for oxygen therapy which is fundamental in managing asthma by reducing the extent or destructiveness of the symptoms. Furthermore, treatments like oxygen therapy, and increased revenues are tied to the fact that the healthcare system in the region pays more attention to respiratory disorders as its foundation is being built up. As a result of development and innovations in the field of health, delivery systems for oxygen have improved and there is therefore increased capacity of the patient to be well cared for in both the hospital and at home. Enhancing the patient base, advanced treatment solutions, and enhancing consciousness levels regarding asthma management are major factors augmenting the oxygen therapy market share across the region.
Latin America Oxygen Therapy Market Analysis
With rising disposable income, more individuals in Latin America are seeking home healthcare solutions, including oxygen therapy. For instance, between 2021 and 2040, Latin America's total disposable income is projected to rise by nearly 60%, driven by regional disparities narrowing and technological advancements. This growth boosts demand for home healthcare services by enhancing affordability and accessibility. This economic growth is enabling a broader section of the population to afford at-home treatments for chronic respiratory conditions. The ability to manage health from the comfort of home is becoming more appealing, especially as the quality of healthcare services improves. Patients with respiratory illnesses prefer using client-transportable oxygen concentration equipment, which can be relocated in the home setting. Common hospital-based treatments are much more convenient and economical. The increased affordability of oxygen therapy as a home healthcare product along with easier access to healthcare products has played a vital part in the advancement of the therapy in the region. Rising disposable income is therefore central to the home health care oxygen therapy industry, thus driving the market forward.
Middle East and Africa Oxygen Therapy Market Analysis
Healthcare facilities in the region have expanded significantly, improving access to critical care and oxygen therapy services. According to the Dubai Healthcare City Authority report, by 2022, Dubai saw a significant expansion in healthcare facilities, with 4,482 private medical establishments, including 56 hospitals, and 55,208 licensed professionals. The Dubai Health Authority forecasts a 10-15% growth in medical professionals and a 3-6% rise in facilities through 2023 and beyond. The increased availability of medical centers and specialized healthcare providers has facilitated easier access to therapies for individuals with respiratory needs. With an emphasis on upgrading healthcare infrastructure, there has been a significant push to enhance treatment options, including oxygen therapy, for patients with respiratory disorders. The expansion of healthcare facilities ensures that more people can access essential services, such as oxygen therapy, which is vital for those suffering from chronic respiratory conditions. This development is creating a more favorable environment for the growth of oxygen therapy adoption across the region.
The global oxygen therapy market is highly saturated, and companies are striving to maintain their position through innovation of products, strategic partnerships, and new product launches. One of the major trends is the creation of portable and wearable oxygen delivery devices for meeting the growing home healthcare equipment market. Additionally, to enhance the efficiency, flexibility, and portability of a device, companies are increasingly underlining the significance of research and development (R&D). Other factors that are influencing the market include the approval of regulations for advanced technology and developing collaborations with the healthcare sector. Also, through acquisitions and mergers, competition is being pressed through market consolidation and improvements in product offerings. They point to the emergence of new respiratory ailments on the market and the shift towards home-based solutions.